Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 215, pseudogene (RNU6-215P) is a pseudogene member of the U6 small nuclear RNA gene family. Pseudogenes are genomic sequences that resemble known genes but are typically non-functional; RNU6-215P is presumed not to produce a functional RNA product, and there is no evidence it functions in spliceosomal activity. The functional U6 small nuclear RNA is essential for the spliceosome and pre-mRNA splicing, but this designation applies to functional U6 RNAs, not pseudogenes such as RNU6-215P. RNU6-215P does not act as a receptor, enzyme, transporter, or drug target and is not implicated in disease or therapeutic modulation. Key distinctions: - RNU6-215P is a noncoding RNA pseudogene and not a functional RNA nor a therapeutic target. - Its sequence is related to U6 small nuclear RNA, but it does not contribute to the spliceosome or RNA splicing. - There are no known interactions with drugs, disease roles, biomarker usages, or safety issues relevant to this pseudogene.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 215, pseudogene (RNU6-215P).